Patents by Inventor Robin Andrew Quirk
Robin Andrew Quirk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11904070Abstract: The invention relates to a scaffold material composition for forming a solid tissue scaffold, the composition comprising a plurality of hollow polymer pellets, each pellet comprising an open hollow extending through the pellet, and wherein the plurality of hollow polymer pellets are capable of interlinking and setting into a solid scaffold. The invention further relates to associated compositions, uses, method of treatment and kits associated with such material.Type: GrantFiled: February 12, 2018Date of Patent: February 20, 2024Assignee: LOCATE THEAPEUTICS LIMITEDInventors: Antonio Leonardi, Helen Celia Cox, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Patent number: 10933167Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: GrantFiled: August 9, 2018Date of Patent: March 2, 2021Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Publication number: 20200368387Abstract: The invention relates to a scaffold material composition for forming a solid tissue scaffold, the composition comprising a plurality of hollow polymer pellets, each pellet comprising an open hollow extending through the pellet, and wherein the plurality of hollow polymer pellets are capable of interlinking and setting into a solid scaffold. The invention further relates to associated compositions, uses, method of treatment and kits associated with such material.Type: ApplicationFiled: February 12, 2018Publication date: November 26, 2020Applicant: Locate Therapeutics LimitedInventors: Antonio LEONARDI, Helen Celia COX, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Patent number: 10232087Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: March 29, 2004Date of Patent: March 19, 2019Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Patent number: 10195309Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: GrantFiled: February 1, 2008Date of Patent: February 5, 2019Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Publication number: 20180361029Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: ApplicationFiled: August 9, 2018Publication date: December 20, 2018Inventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Patent number: 10086113Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: March 29, 2004Date of Patent: October 2, 2018Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Patent number: 9486558Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: GrantFiled: May 8, 2008Date of Patent: November 8, 2016Assignee: LOCATE THERAPEUTICS LIMITEDInventors: Richard Melville France, Robin Andrew Quirk
-
Publication number: 20160175482Abstract: An injectable agent delivery system comprising a composition that comprises: an agent for sustained delivery located within discrete particles; and an injectable scaffold material comprising discrete particles which are capable of interacting to form a scaffold, and uses thereof.Type: ApplicationFiled: August 8, 2014Publication date: June 23, 2016Applicant: LOCATE THERAPEUTICS LIMITEDInventors: Robin Andrew QUIRK, Helen Celia COX, Kevin Morris SHAKESHEFF
-
Patent number: 8877456Abstract: The invention relates to a method for determining the quantity of pre-synaptic neuromuscular blocking substance (notably botulinum toxin) contained in a sample. In one aspects, the method comprises the following steps: (i) determining the minimum voltage Vm needed to induce the contraction of muscle tissue, said muscle tissue being connected to an electrical stimulator through a motor nerve and preferably immersed in an oxygenated physiological buffer containing glucose; (ii) adding the sample containing the pre-synaptic neuromuscular blocking substance; (iii) electrically stimulating, at a voltage at least equal to Vm, the muscle tissue at certain time intervals; (iv) comparing the effect induced by the sample to the effect induced by a reference substance and thereby determining the quantity of the pre-synaptic neuromuscular blocking substance in the sample.Type: GrantFiled: February 20, 2004Date of Patent: November 4, 2014Assignee: Ipsen Biopharm LimitedInventors: Andrew Martin Pickett, Robin Andrew Quirk, Richard Melville France, Lisa Anne Riccalton-Banks
-
Publication number: 20120063997Abstract: An injectable, agent delivery system comprising a composition comprising: (i) an injectable scaffold material comprising discrete particles, which are capable of interacting to form a scaffold; and (ii) a carrier comprising an agent for delivery. The product can have a pharmaceutical use or use in cosmetic surgery; in particular it can be used in tissue regeneration or reconstruction. The agent for delivery may be a therapeutically, prophylactically or diagnostically active substance.Type: ApplicationFiled: March 5, 2010Publication date: March 15, 2012Applicant: REGENTEC LIMITEDInventors: Cheryl Hunter, Kevin Morris Shakessheff, Robin Andrew Quirk
-
Publication number: 20100063175Abstract: A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.Type: ApplicationFiled: February 1, 2008Publication date: March 11, 2010Applicant: REGENTEC LIMITEDInventors: Patrick Ginty, Robin Andrew Quirk, Kevin Morris Shakesheff
-
Publication number: 20080241248Abstract: A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.Type: ApplicationFiled: May 8, 2008Publication date: October 2, 2008Applicant: REGENTEC LTD.Inventors: Richard Melville France, Robin Andrew Quirk